ClinicalTrials.Veeva

Menu

Femoral Block With or Without Ropivacaine for Analgesia After Total Knee Replacement (TKR)

H

Hopital de l'Enfant-Jesus

Status and phase

Completed
Phase 2
Phase 1

Conditions

Total Knee Replacement

Treatments

Drug: Ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT00910013
PEJ-340

Details and patient eligibility

About

Total knee replacement is a painful procedure. Many solutions have been proposed to diminish the post-operative doses of narcotics, including nerve blocks.

The purpose of the study is to compare if the adjunction of intra-articular ropivacaine to a femoral block is more effective on narcotics consumption than the block alone after TKR.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary total knee replacement
  • Age > 18 years old
  • Accept the study

Exclusion criteria

  • Revision surgery
  • Use of anticoagulants drugs
  • Neurologic disorder
  • Unable to sign consent form

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

80 participants in 1 patient group

Ropivacaine + femoral block
Experimental group
Description:
After the surgery is proceeded and after the closure of the joint capsule, 20 cc of ropivacaine 0.5% is inserted intra-articular through a catheter.
Treatment:
Drug: Ropivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems